Andere talen ARCA biopharma, Inc.

Aandelen

ABIO

US00211Y5069

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,26 ^USD	0,00%		-8,94%	+91,76%

25/04	ARCA biopharma, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
04/04	ARCA biopharma, Inc. Kondigt wijzigingen in het management aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	25/04
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
North American Morning Briefing : Stock Futures -2-	19/04
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10/04
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05/04
ARCA biopharma, Inc. Announces Management Changes	04/04
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer	04/04
Sector Update: Health Care Stocks Softer Late Afternoon	03/04
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03/04
Top Midday Gainers	03/04
Sector Update: Health Care Stocks Rise Wednesday Afternoon	03/04
Sector Update: Health Care	03/04
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge	03/04
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03/04
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03/04
Oruka Therapeutics announced that it expects to receive $275 million in funding	03/04
ARCA biopharma Announces 2023 Financial Results	01/02
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/02
ARCA biopharma Announces Third Quarter 2023 Financial Results	18-10-23
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ARCA biopharma, Inc.

Aandelen

ABIO

US00211Y5069

Andere talen

Filters